Glofitamab for Relapsed/Refractory Large B-cell Lymphomas | Joshua Brody, MD |

Dr. Joshua Brody from the Icahn School of Medicine at Mount Sinai talks about the use of glofitamab for patients with large B-cell lymphoma.
Link to ASH playlist: healthtree.org...
ASH Abstract: Fixed-Duration Glofitamab Monotherapy Continues to Demonstrate Durable Responses in Patients with Relapsed or Refractory Large B-Cell Lymphoma: 3-Year Follow-up from a Pivotal Phase II Study
#ASH24 #lymsm #dlbcl
Follow HealthTree: linktr.ee/Heal...